Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan C Whiting

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Diabetes|November 23, 2013
Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetesLinda Yip, Cariel Taylor, Chan C Whiting, et al.
The FEBS Journal|November 17, 2010
GRAIL: a unique mediator of CD4 T-lymphocyte unresponsivenessChan C Whiting, Leon L Su, Jack T Lin, et al.
Annals of the New York Academy of Sciences|March 23, 2007
Dosing and timing effects of anti-CD40L therapy: predictions from a mathematical model of type 1 diabetesKapil G Gadkar, Lisl K M Shoda, Huub T C Kreuwel, et al.
Annals of the New York Academy of Sciences|March 23, 2007
The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetesYanan Zheng, Huub T C Kreuwel, Daniel L Young, et al.
Arthritis Research & Therapy|May 19, 2015
Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapyNitya Nair, Henrik E Mei, Shih-Yu Chen, et al.
Diabetes|September 5, 2014
Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetesLinda Yip, Rebecca Fuhlbrigge, Cariel Taylor, et al.
Plos One|July 22, 2015
Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human AgingChan C Whiting, Janet Siebert, Aaron M Newman, et al.
Blood|March 8, 2008
Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytesScot D Liu, Chan C Whiting, Tamar Tomassian, et al.
Cancer Research Communications|August 10, 2023
Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing TumorsBrian J Francica, Anja Holtz, Justine Lopez, et al.
Immunity|August 23, 2005
A comprehensive review of interventions in the NOD mouse and implications for translationLisl K M Shoda, Daniel L Young, Saroja Ramanujan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Diabetes|November 23, 2013
Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetesLinda Yip, Cariel Taylor, Chan C Whiting, et al.
The FEBS Journal|November 17, 2010
GRAIL: a unique mediator of CD4 T-lymphocyte unresponsivenessChan C Whiting, Leon L Su, Jack T Lin, et al.
Annals of the New York Academy of Sciences|March 23, 2007
Dosing and timing effects of anti-CD40L therapy: predictions from a mathematical model of type 1 diabetesKapil G Gadkar, Lisl K M Shoda, Huub T C Kreuwel, et al.
Annals of the New York Academy of Sciences|March 23, 2007
The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetesYanan Zheng, Huub T C Kreuwel, Daniel L Young, et al.
Arthritis Research & Therapy|May 19, 2015
Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapyNitya Nair, Henrik E Mei, Shih-Yu Chen, et al.
Diabetes|September 5, 2014
Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetesLinda Yip, Rebecca Fuhlbrigge, Cariel Taylor, et al.
Plos One|July 22, 2015
Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human AgingChan C Whiting, Janet Siebert, Aaron M Newman, et al.
Blood|March 8, 2008
Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytesScot D Liu, Chan C Whiting, Tamar Tomassian, et al.
Cancer Research Communications|August 10, 2023
Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing TumorsBrian J Francica, Anja Holtz, Justine Lopez, et al.
Immunity|August 23, 2005
A comprehensive review of interventions in the NOD mouse and implications for translationLisl K M Shoda, Daniel L Young, Saroja Ramanujan, et al.
Pageof 2